Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review

February 2021 | 82 pages | ID: BC43062F351EN
GlobalData

Abstracts

Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instruments. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; pre-fillable drug delivery systems; respiratory ventilation and diagnostics equipment and consumables; products for the safe collection and transport of diagnostics specimens; instruments and reagent systems to detect a broad range of infectious diseases, and cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company sells its products in the Americas, Europe, the Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US.

Becton Dickinson and Co Key Recent Developments

Feb 22,2021: BD and Scanwell Health partner to create at-home SARS-CoV-2 test
Feb 10,2021: Dev Kurdikar Named President of BD Diabetes Care
Feb 04,2021: BD announces first fiscal quarter results; Raises fiscal 2021 guidance
Feb 02,2021: First-of-its-kind randomized clinical trial published in "The Lancet Infectious Diseases" outlines potential new standard-setting best practices for peripheral IV catheters
Jan 28,2021: BD named a Best Place to Work for LGBTQ Equality for fourth consecutive year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

Table of Contents
List of Tables
List of Figures

SECTION 1 - ABOUT THE COMPANY

Becton Dickinson and Co - Key Facts
Becton Dickinson and Co - Key Employees
Becton Dickinson and Co - Key Employee Biographies
Becton Dickinson and Co - Major Products and Services
Becton Dickinson and Co - History
Becton Dickinson and Co - Company Statement
Becton Dickinson and Co - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Business Unit

SECTION 2 – COMPANY ANALYSIS

Company Overview
Becton Dickinson and Co - Business Description
Business Segment: BD Interventional
Overview
Performance
Business Segment: BD Life Sciences
Overview
Performance
Business Segment: BD Medical
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Greater Asia
Target Markets
Performance
Geographical Segment: Others
Target Markets
Performance
Geographical Segment: The US
Performance
R&D Overview
Becton Dickinson and Co - Corporate Strategy
Becton Dickinson and Co - SWOT Analysis
SWOT Analysis - Overview
Becton Dickinson and Co - Strengths
Becton Dickinson and Co - Weaknesses
Becton Dickinson and Co - Opportunities
Becton Dickinson and Co - Threats
Becton Dickinson and Co - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES

Becton Dickinson and Co, Medical Equipment, Deals By Year, 2015 to YTD 2021
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2015 to YTD 2021
Becton Dickinson and Co, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 22, 2021: BD and Scanwell Health partner to create at-home SARS-CoV-2 test
Feb 10, 2021: Dev Kurdikar Named President of BD Diabetes Care
Feb 04, 2021: BD announces first fiscal quarter results; Raises fiscal 2021 guidance
Feb 02, 2021: First-of-its-kind randomized clinical trial published in "The Lancet Infectious Diseases" outlines potential new standard-setting best practices for peripheral IV catheters
Jan 28, 2021: BD named a Best Place to Work for LGBTQ Equality for fourth consecutive year
Jan 26, 2021: BD names CEO Tom Polen as Chairman of the Board
Jan 12, 2021: BD provides updates to its fiscal 2021 financial outlook and intends to comment on its preliminary first fiscal quarter revenue performance during today's webcast At The 39th Annual J.P. Morgan Healthcare Conference
Dec 17, 2020: BD: Focusing on the future: setting Climate Change targets
Dec 16, 2020: BD surpasses 1 billion injection device orders in support of COVID-19 vaccination efforts around the world
Dec 14, 2020: BD publishes its inaugural cybersecurity annual report

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Becton Dickinson and Co, Key Facts
Becton Dickinson and Co, Key Employees
Becton Dickinson and Co, Key Employee Biographies
Becton Dickinson and Co, Major Products and Services
Becton Dickinson and Co, History
Becton Dickinson and Co, Other Locations
Becton Dickinson and Co, Subsidiaries
Becton Dickinson and Co, Business Unit
Becton Dickinson and Co, Key Competitors
Becton Dickinson and Co, Ratios based on current share price
Becton Dickinson and Co, Annual Ratios
Becton Dickinson and Co, Annual Ratios (Cont...1)
Becton Dickinson and Co, Annual Ratios (Cont...2)
Becton Dickinson and Co, Interim Ratios
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2015 to YTD 2021
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2015 to YTD 2021
Becton Dickinson and Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Becton Dickinson and Co, Performance Chart (2016 - 2020)
Becton Dickinson and Co, Ratio Charts
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2015 to YTD 2021
Becton Dickinson and Co, Medical Equipment, Deals by Type, 2015 to YTD 2021

COMPANIES MENTIONED

Repro Med Systems Inc
OpGen Inc
Medtronic Plc
F. Hoffmann-La Roche Ltd
Exalenz Bioscience Ltd
Cardiovascular Systems Inc
Bio-Rad Laboratories Inc
bioMerieux SA
Baxter International Inc
B. Braun Melsungen AG